NCT02893618 A 5 Treatment Period Pharmacokinetic Study Evaluating Dose Proportionality and Food Effects of Diazoxide Choline Controlled-Release Tablet (DCCR) Status UNKNOWN Phase PHASE2
NCT02844933 Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome Status TERMINATED Phase PHASE2
NCT02810483 Study of the Efficacy of Topiramate in Patients With Prader Willi Syndrome Over 8 Weeks Status TERMINATED Phase PHASE3
NCT02804373 Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome Status COMPLETED Phase PHASE2/PHASE3
NCT02670694 Sleep Abnormalities in Rare Genetic Disorders: AS, RTT, and PW Status COMPLETED Phase N/A
NCT02629991 Oxytocin vs. Placebo for the Treatment Hyperphagia in Children and Adolescents With Prader-Willi Syndrome Status COMPLETED Phase PHASE2
NCT02529085 PWS European Blood Bank for Infants and Controls From 0 to 48 Months Status COMPLETED Phase NA
NCT02311673 Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome Status COMPLETED Phase PHASE2
NCT02297022 Deep Brain Stimulation for the Treatment of Obesity in Patients With Prader-Willi Syndrome Status UNKNOWN Phase PHASE1
NCT02205450 Growth Hormone in Children Under 2 Years With Prader-Willi in Hospital of Sabadell Status COMPLETED Phase N/A
NCT02204163 Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome Status COMPLETED Phase PHASE3
NCT02179151 Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome Status TERMINATED Phase PHASE3
NCT02034071 Clinical Study of Diazoxide Choline Controlled-Release Tablet (DCCR) in Patients With Prader-Willi Syndrome Status COMPLETED Phase PHASE1/PHASE2
NCT01863017 Pilot Study of Startle-response Test to Assess Transcranial Direct Current Stimulation-induced Modulation of Hyperphagia in Prader-Willi Syndrome Status COMPLETED Phase NA
NCT01818921 An Efficacy, Safety, and Pharmacokinetics Study of Beloranib in Obese Subjects With Prader-Willi Syndrome Status COMPLETED Phase PHASE2
NCT01622751 Plasma Adiponectin Level and Sleep Structures in Children With Prader-Willi Syndrome Status COMPLETED Phase N/A
NCT01548521 Tolerance of Intranasal Administration of OT in Prader-Willi Newborn Babies Status COMPLETED Phase PHASE1/PHASE2